These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15171957

  • 21. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ, Tóth-Zsámboki E, Vargová K, László A, Masszi T, Kerecsen G, Préda I, Kiss RG.
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [Abstract] [Full Text] [Related]

  • 22. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, Serebruany V.
    Thromb Res; 2007 Nov; 119(3):277-84. PubMed ID: 16563469
    [Abstract] [Full Text] [Related]

  • 23. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
    Vilahur G, Pena E, Padró T, Badimon L.
    Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
    [Abstract] [Full Text] [Related]

  • 24. ADP receptor-blocker thienopyridines: chemical structures, mode of action and clinical use. A review.
    Hashemzadeh M, Goldsberry S, Furukawa M, Khoynezhad A, Movahed MR.
    J Invasive Cardiol; 2009 Aug; 21(8):406-12. PubMed ID: 19652255
    [Abstract] [Full Text] [Related]

  • 25. Emergence of the concept of platelet reactivity monitoring of response to thienopyridines.
    Bonello L, De Labriolle A, Scheinowitz M, Lemesle G, Roy P, Steinberg DH, Pinto Slottow TL, Pakala R, Pichard AD, Barragan P, Camoin-Jau L, Dignat-George F, Paganelli F, Waksman R.
    Heart; 2009 Aug; 95(15):1214-9. PubMed ID: 19196732
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of clopidogrel in the management of ischemic heart disease.
    Galla JM, Lincoff AM.
    Curr Opin Cardiol; 2007 Jul; 22(4):273-9. PubMed ID: 17556877
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel.
    Schrör K.
    Vasc Med; 1998 Jul; 3(3):247-51. PubMed ID: 9892518
    [Abstract] [Full Text] [Related]

  • 35. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z, Kala P.
    Clin Ther; 2008 Jul; 30 Pt 2():2191-202. PubMed ID: 19281914
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clopidogrel resistance.
    Oqueli E, Hiscock M, Dick R.
    Heart Lung Circ; 2007 Jul; 16 Suppl 3():S17-28. PubMed ID: 17611155
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):657-66. PubMed ID: 17291930
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.